In high-surgical-risk patients, mitral valve-in-valve (MViV), valve-in-ring (MViR), or valve-in-mitral annular calcification (ViMAC) procedures are associated with long-term improvement in heart failure symptoms and quality of life among survivors, according to findings from the MITRAL trial.